GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » E10

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) E10 : ¥0.89 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Tianjin Pharmaceutical Da Ren Tang Group's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.500. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.89 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group's average E10 Growth Rate was 9.90% per year. During the past 3 years, the average E10 Growth Rate was 7.70% per year. During the past 5 years, the average E10 Growth Rate was 7.60% per year. During the past 10 years, the average E10 Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Tianjin Pharmaceutical Da Ren Tang Group was 34.70% per year. The lowest was 6.80% per year. And the median was 17.35% per year.

As of today (2024-05-28), Tianjin Pharmaceutical Da Ren Tang Group's current stock price is ¥35.09. Tianjin Pharmaceutical Da Ren Tang Group's E10 for the quarter that ended in Mar. 2024 was ¥0.89. Tianjin Pharmaceutical Da Ren Tang Group's Shiller PE Ratio of today is 39.43.

During the past 13 years, the highest Shiller PE Ratio of Tianjin Pharmaceutical Da Ren Tang Group was 109.46. The lowest was 19.34. And the median was 37.39.


Tianjin Pharmaceutical Da Ren Tang Group E10 Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group E10 Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.68 0.73 0.78 0.85

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.84 0.85 0.85 0.89

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Shiller PE Ratio falls into.



Tianjin Pharmaceutical Da Ren Tang Group E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tianjin Pharmaceutical Da Ren Tang Group's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.5/115.2271*115.2271
=0.500

Current CPI (Mar. 2024) = 115.2271.

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data

per share eps CPI Adj_EPS
201406 0.130 98.200 0.153
201409 0.080 98.900 0.093
201412 0.130 99.000 0.151
201503 0.160 99.900 0.185
201506 0.160 99.500 0.185
201509 0.130 100.500 0.149
201512 0.150 100.600 0.172
201603 0.156 102.200 0.176
201606 0.180 101.400 0.205
201609 0.120 102.400 0.135
201612 0.090 102.600 0.101
201703 0.170 103.200 0.190
201706 0.190 103.100 0.212
201709 0.110 104.100 0.122
201712 0.150 104.500 0.165
201803 0.230 105.300 0.252
201806 0.178 104.900 0.196
201809 0.113 106.600 0.122
201812 0.209 106.500 0.226
201903 0.247 107.700 0.264
201906 0.203 107.700 0.217
201909 0.130 109.800 0.136
201912 0.230 111.200 0.238
202003 0.220 112.300 0.226
202006 0.200 110.400 0.209
202009 0.200 111.700 0.206
202012 0.240 111.500 0.248
202103 0.280 112.662 0.286
202106 0.320 111.769 0.330
202109 0.260 112.215 0.267
202112 0.140 113.108 0.143
202203 0.260 114.335 0.262
202206 0.350 114.558 0.352
202209 0.330 115.339 0.330
202212 0.170 115.116 0.170
202303 0.520 115.116 0.521
202306 0.420 114.558 0.422
202309 0.170 115.339 0.170
202312 0.170 114.781 0.171
202403 0.500 115.227 0.500

Add all the adjusted EPS together and divide 10 will get our e10.


Tianjin Pharmaceutical Da Ren Tang Group  (SHSE:600329) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tianjin Pharmaceutical Da Ren Tang Group's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=35.09/0.89
=39.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Tianjin Pharmaceutical Da Ren Tang Group was 109.46. The lowest was 19.34. And the median was 37.39.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Tianjin Pharmaceutical Da Ren Tang Group E10 Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
Executives
Li Li Qun Director
Ni Zhen Guo senior management
Yu Hong Directors, senior managers
Zhou Hong Directors, senior managers
Zhang Jian senior management
Niu Sheng Fang senior management
Wang Xin senior management
Wang Mai Director
Jiao Yan senior management
Hao Fei Fei Director
Zhang Bao Tong senior management
Wang Zhi Qiang senior management
Liang Xiu Qin senior management
Li Jia Sheng Supervisors
Zhang Hong Kui Director

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines